Topic: ILD Induced by Anti-ERBB2 Antibody-Drug Conjugates

Forum: HER2+ (Positive) Breast Cancer — Testing, treatment, side effects, and more.

Posted on: Jan 16, 2022 08:00AM

Posted on: Jan 16, 2022 08:00AM

nnguyen wrote:

Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-Drug Conjugates

https://jamanetwork.com/journals/jamaoncology/article-abstract/2784880

Be sure to read the comment section.

Nguyen

Log in to post a reply

Page 1 of 1 (1 results)

Log in to post a reply

Jan 16, 2022 05:20PM - edited Jan 16, 2022 05:21PM by olma61

yes here's the trade off for the effectiveness of Enhertu

I saw talk of making TDXD the first line treatment for HER2+, for this reason I don't think they should do s

10/30/2017 Xgeva for bone mets 5/31/2018 Taxol finished! "If one just keeps on walking, everything will be all right” - Kierkegaard Dx 8/3/2017, IDC, Right, 2cm, Stage IV, metastasized to bone, Grade 2, ER+/PR+, HER2+, IHC Targeted Therapy 10/28/2017 Perjeta (pertuzumab) Targeted Therapy 10/28/2017 Herceptin (trastuzumab) Chemotherapy 10/29/2017 Taxol (paclitaxel) Hormonal Therapy 5/14/2018 Arimidex (anastrozole) Radiation Therapy 5/29/2019 External Local Metastases 5/29/2019 Radiation therapy: Bone

Page 1 of 1 (1 results)

Scroll to top button